Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Low Disease Relapse and High Survival in Non-Myeloablative Two-Step Haploidentical Transplant, Results of a Prospective Trial

Xia Bi, Dolores A. Grosso, John L. Wagner, Joanne Filicko-O'Hara, William O'Hara, Neal Flomenberg, Usama Gergis

Blood (2023) 142 (Supplement 1): 4908.

https://doi.org/10.1182/blood-2023-178779

Published: 2023

Journal Articles

Outcome of Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide - a Single Center Experience

Yang Yang, Adam F. Binder, Xia Bi, Joanne Filicko-O'Hara, William O'Hara, Neal Flomenberg, Dolores A. Grosso, John L. Wagner, Arpona Dev Nath, Sikemi Ibikunle, Eliabeth Spitz, Usama Gergis

Blood (2023) 142 (Supplement 1): 7110.

https://doi.org/10.1182/blood-2023-173576

Published: 2023

Journal Articles

Characteristics and Clinical Outcomes of Patients with Acute Myeloid Leukemia with TP53 Mutations - a Single Center Experience

Xia Bi, Zoe Begun, Dolores A. Grosso, Margaret Kasner, Gina Keiffer, Joanne Filicko-O'Hara, William O'Hara, John L. Wagner, Lindsay Wilde, Neal Flomenberg, Zixuan Wang, Usama Gergis

Blood (2023) 142 (Supplement 1): 2847.

https://doi.org/10.1182/blood-2023-179931

Published: 2023

Journal Articles

Effect of Prebiotic Rich Diet on Gut Microbiome in Patients (Pts) Undergoing Stem Cell Transplants- Results of Phase I Study (NCT04629430)- Clinical Outcomes

Indumathy Varadarajan, Danyelle Coley, David Stewart Brighton, Bethany Jablonski Horton, Leonid Volodin, John L. Wagner, Karen K. Ballen, Melanie Rutkowski

Blood (2023) 142 (Supplement 1): 6885.

https://doi.org/10.1182/blood-2023-187289

Published: 2023

Journal Articles

The Two-Step Approach to Haploidentical Transplant: Can Altering Timing in the Conditioning Regimen Increase Graft Versus Tumor Effects?

Dolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, William O'Hara, Shannon Rudolph, John L. Wagner, Usama Gergis, Neal Flomenberg

Blood (2021) 138 (Supplement 1): 1845.

https://doi.org/10.1182/blood-2021-146913

Published: 2021

Journal Articles

Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)

Blood (2021) 138 (Supplement 1): 3880.

https://doi.org/10.1182/blood-2021-148652

Published: 2021

Journal Articles

Loss of an Immunodominant HLA-Α *01:01 Restricted Epitope for CD8+ Cytotoxic T Lymphocytes (CTLs) in the Delta Variant of COVID-19: An Example of Immunologic Escape and Implications for Immunologic Treatment

Neal Flomenberg, Dolores Grosso, Yuri Sykulev, Nadezhda Anikeyeva, Yanping Huang, Michael Sun, Kaitlin Keck, Allyson O'Connor, Alexis Peedin, Julie Karp, Phyllis Flomenberg, AnnaMaria Chang, Patricia Henwood, Kristin Rising, Neda Nikbakht, Liza McGuire, Samuel Flomenberg, Ryan Saadi, John L. Wagner

Blood (2021) 138 (Supplement 1): 738.

https://doi.org/10.1182/blood-2021-147487

Published: 2021

Journal Articles

Encouraging Results of Haploidentical Transplantation in Older Patents Using the Two-Step T Cell Tolerization Platform - Results of a Prospective Trial

Dolores Grosso, DNP, CRNP, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, John L. Wagner, MD, William O'Hara, PharmD, Shaik Rashid, MD, Gina Mateja, BA, Usama Gergis, MD, Neal Flomenberg, MD

Blood (2020) 136 (Supplement 1): 40.

https://doi.org/10.1182/blood-2020-136377

Published: 2020

Journal Articles

The Two-Step Approach to Haploidentical Hematopoietic Stem Cell Transplantation (HI HSCT): 15 Years of Transplants in Patients 19-78 Years Old

Dolores Grosso, DNP, CRNP, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, John L. Wagner, MD, William O'Hara, PharmD, Shaik Rashid, MD, Usama Gergis, MD, Neal Flomenberg, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-139866

Published: 2020

Journal Articles

COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience

Lindsay Wilde, MD, Adam F. Binder, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, John L. Wagner, MD, Onder Alpdogan, MD, Margaret Kasner, MDMSc, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Neil Palmisiano, MDMS, Gina Keiffer, MD, Dolores Grosso, DNP, CRNP, Michael Millenson, Amy R. MacKenzie, MD, Allison Zibelli, MD, Neal Flomenberg, MD, Pierluigi Porcu, MD, Usama Gergis, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-140719

Published: 2020

Journal Articles

High Survival in Patients with Myelofibrosis Undergoing a Two-Step Approach to Hematopoietic Stem Cell Transplantation (HSCT): Effects of Donor Source and Pre-HSCT Splenic Therapy on Outcomes

Shaik Rashid, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, John L. Wagner, MD, William O'Hara, PharmD, Usama Gergis, MD, Neal Flomenberg, MD, Dolores Grosso, DNP, CRNP

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-139630

Published: 2020

Journal Articles

Vaccination Response after Autologous Stem Cell Transplantation

Onder Alpdogan, MD, Jennifer Hong, MD, Thomas R. Klumpp, MD, Abdullateef O Abdulkareem, MD MPH, Adam F. Binder, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Dolores Grosso, DNP, CRNP, Margaret Kasner, MDMSc, Ubaldo Martinez-Outschoorn, MD, Neil Palmisiano, MDMS, Lindsay Wilde, MD, Pierluigi Porcu, MD, Usama Gergis, MD, John L. Wagner, MD, Neal Flomenberg, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-141269

Published: 2020

Journal Articles

Results of a Phase I/II Study of Bendamustine in Combination with Ofatumumab, Carboplatin and Etoposide (BOCE) for Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas

Jonathan Pan, MD, Sushil Ghimire, MD, Tingting Zhan, PhD, Onder Alpdogan, MD, Andrew E. Chapman, DO, Matthew Carabasi, MD, Ubaldo Martinez-Outschoorn, MD, Lewis J. Rose, MD, Michael Ramirez, MD, John L Wagner, MD, Barbara Pro, MD, Mark A. Weiss, MD, Neal Flomenberg, MD, Pierluigi Porcu, MD, Joanne Filicko-O'Hara, MD, Sameh Gaballa, MD

Blood (2019) 134 (Supplement_1): 5318.

https://doi.org/10.1182/blood-2019-125836

Published: 2019

Journal Articles

2 Step Myeloablative Haploidentical Transplant (HI MA HSCT) in Intermediate and High-Risk Patients-Changing the Timing of the 2 Step Approach

Dolores Grosso, DNP, CRNP, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Sameh Gaballa, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Neil Palmisiano, MD, William O'Hara, PharmD, John L Wagner, MD, Pierluigi Porcu, MD, Neal Flomenberg, MD

Blood (2018) 132 (Supplement 1): 4661.

https://doi.org/10.1182/blood-2018-99-110815

Published: 2018

Journal Articles

HSCT Engraftment Kinetics: Differences in Chimerism between Haploidentical (HI) and Matched Related (MR) Transplant Recipients (HSCT) after the 2 Step Approach

Dolores Grosso, DNP, CRNP, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Sameh Gaballa, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Neil Palmisiano, MD, Pierluigi Porcu, MD, William O'Hara, PharmD, John L Wagner, MD, Neal Flomenberg, MD

Blood (2018) 132 (Supplement 1): 3371.

https://doi.org/10.1182/blood-2018-99-117364

Published: 2018

Journal Articles

Differences in Allogeneic Product T-Cell Subsets According to Donor Age: Associations with Immune Reconstitution and Acute Graft Versus Host Disease (aGVHD) in Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

Jason Chen, MD, Jonathan Pan, MD, John L. Wagner, MD, Michael Sun, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Sameh Gaballa, MD, Margaret Kasner, MD, Thomas Klumpp, MD, Neil Palmisiano, MD, Ubaldo Martinez-Outschoorn, MD, Pierluigi Porcu, MD, Neal Flomenberg, MD, Dolores Grosso, DNP, CRNP

Blood (2017) 130 (Supplement 1): 3200.

https://doi.org/10.1182/blood.V130.Suppl_1.3200.3200

Published: 2017

Journal Articles

The Presence of Recipient CMV Immunodominant Human Leukocyte Antigen (HLA) Alleles Affect Outcomes after Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

Dolores Grosso, DNP, CRNP, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Sameh Gaballa, MD, Margaret Kasner, MD, Thomas Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, William O'Hara, PharmD, Neil Palmisiano, MD, John L. Wagner, MD, Pierluigi Porcu, MD, Neal Flomenberg, MD

Blood (2017) 130 (Supplement 1): 1959.

https://doi.org/10.1182/blood.V130.Suppl_1.1959.1959

Published: 2017

Journal Articles

A Phase II Trial of Sirolimus with Standard Induction Chemotherapy in Patients with De Novo Acute Myeloid Leukemia

Neil Palmisiano, MD, Grace Jeschke, PhD, Benjamin E Leiby, PhD, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Sameh Gaballa, MD, Dolores Grosso, DNP, CRNP, Thomas R. Klumpp, MD, Ubaldo Martinez Outschoorn, MD, John L Wagner, MD, Martin Carroll, MD, Pierluigi Porcu, MD, Neal Flomenberg, MD, Alexander E. Perl, MD, Margaret Kasner, MD

Blood (2017) 130 (Supplement 1): 3858.

https://doi.org/10.1182/blood.V130.Suppl_1.3858.3858

Published: 2017

Journal Articles

A Phase II Study of Azacitidine and Sirolimus for the Treatment of Acute Myeloid Leukemia (AML) Refractory to or Not Eligible for Intensive Chemotherapy or High Risk Myelodysplastic Syndrome (MDS)

Neil Palmisiano, MD, Grace Jeschke, PhD, Lindsay Wilde, MD, Benjamin E Leiby, PhD, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Sameh Gaballa, MD, Dolores Grosso, DNP, CRNP, Thomas R. Klumpp, MD, Ubaldo Martinez Outschoorn, MD, John L Wagner, MD, Martin Carroll, MD, Pierluigi Porcu, MD, Neal Flomenberg, MD, Alexander E. Perl, MD, Margaret Kasner, MD

Blood (2017) 130 (Supplement 1): 4267.

https://doi.org/10.1182/blood.V130.Suppl_1.4267.4267

Published: 2017

Journal Articles

Detection of Acquired Uniparental Disomy (aUPD) with HLA Typing and Microarray Analysis after T Cell-Containing Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

Dolores Grosso, DNP, Beth Colombe, PhD, Zi-Xuan Wang, PhD, Matthew Carabasi, MD, Onder Alpdogan, MD, Joanne E. Filicko-O'Hara, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Manish Sharma, MD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD

Blood (2015) 126 (23): 3165.

https://doi.org/10.1182/blood.V126.23.3165.3165

Published: 2015

NARROW

Low Disease Relapse and High Survival in Non-Myeloablative Two-Step Haploidentical Transplant, Results of a Prospective Trial

Outcome of Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide - a Single Center Experience

Characteristics and Clinical Outcomes of Patients with Acute Myeloid Leukemia with TP53 Mutations - a Single Center Experience

Effect of Prebiotic Rich Diet on Gut Microbiome in Patients (Pts) Undergoing Stem Cell Transplants- Results of Phase I Study (NCT04629430)- Clinical Outcomes

The Two-Step Approach to Haploidentical Transplant: Can Altering Timing in the Conditioning Regimen Increase Graft Versus Tumor Effects?

Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)

Loss of an Immunodominant HLA-Α *01:01 Restricted Epitope for CD8+ Cytotoxic T Lymphocytes (CTLs) in the Delta Variant of COVID-19: An Example of Immunologic Escape and Implications for Immunologic Treatment

Encouraging Results of Haploidentical Transplantation in Older Patents Using the Two-Step T Cell Tolerization Platform - Results of a Prospective Trial

The Two-Step Approach to Haploidentical Hematopoietic Stem Cell Transplantation (HI HSCT): 15 Years of Transplants in Patients 19-78 Years Old

COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience

High Survival in Patients with Myelofibrosis Undergoing a Two-Step Approach to Hematopoietic Stem Cell Transplantation (HSCT): Effects of Donor Source and Pre-HSCT Splenic Therapy on Outcomes

Vaccination Response after Autologous Stem Cell Transplantation

Results of a Phase I/II Study of Bendamustine in Combination with Ofatumumab, Carboplatin and Etoposide (BOCE) for Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas

2 Step Myeloablative Haploidentical Transplant (HI MA HSCT) in Intermediate and High-Risk Patients-Changing the Timing of the 2 Step Approach

HSCT Engraftment Kinetics: Differences in Chimerism between Haploidentical (HI) and Matched Related (MR) Transplant Recipients (HSCT) after the 2 Step Approach

Differences in Allogeneic Product T-Cell Subsets According to Donor Age: Associations with Immune Reconstitution and Acute Graft Versus Host Disease (aGVHD) in Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

The Presence of Recipient CMV Immunodominant Human Leukocyte Antigen (HLA) Alleles Affect Outcomes after Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

A Phase II Trial of Sirolimus with Standard Induction Chemotherapy in Patients with De Novo Acute Myeloid Leukemia

A Phase II Study of Azacitidine and Sirolimus for the Treatment of Acute Myeloid Leukemia (AML) Refractory to or Not Eligible for Intensive Chemotherapy or High Risk Myelodysplastic Syndrome (MDS)

Detection of Acquired Uniparental Disomy (aUPD) with HLA Typing and Microarray Analysis after T Cell-Containing Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only